FDA Approval Insights: Iberdomide-Based Therapy Adds Another Option for R/R Myeloma

Reports

2

Domains carrying it

2

First reported

28 August 2026

Latest report

30 August 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 28 August 2026FDA Approval Insights: Iberdomide-Based Therapy Adds Another Option for R/R Myelomaonclive.com
2. 30 August 2026Nicholas Richardson: FDA Approves Iberdomide for Multiple Myelomaoncodaily.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• FDA Approves Lerodalcibep Autoinjector for Hypercholesterolemia, Updated Indication2 reports · 2 domains · 17 August 2026
• OncoSil Medical Receives FDA Exemption Approval for Targeted Radiation Device4 reports · 4 domains · 18 August 2026
• Celcuity (CELC) Wins FDA Approval As Investors Weigh Whether The Pullback Is A Buying ...2 reports · 2 domains · 13 August 2026
• FDA Approves Ustekinumab Injection for Pediatric Ulcerative Colitis, Expanding IBD Options ...2 reports · 2 domains · 5 September 2026

◆ Share

◆ Evidence

2 reports · 2 domains

• Nicholas Richardson: FDA Approves Iberdomide for Multiple Myelomaoncodaily.com · 30 August 2026
• FDA Approval Insights: Iberdomide-Based Therapy Adds Another Option for R/R Myelomaonclive.com · 28 August 2026